Mission Bio
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
About Mission Bio
Mission Bio is a company that provides a single-cell multi-omics platform for cancer research. The platform allows researchers to measure single nucleotide variations, copy number variations, and protein data from the same cell. Mission Bio's solutions provide insights into clonal heterogeneity, which helps with disease progression and therapy response.
Company Facts
- Headquarters
- San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Total Funding
- $150,898,729
- Last Funding Type
- series_unknown
- Last Funding Date
- 2025-08-05
- Website
- missionbio.com
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Health Care, Oncology
Social Links
Canonical: https://fsome.com/organization/mission-bio-111211 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.